Motilin is an intestinal peptide that stimulates contraction of gut smooth
muscle. The motilin receptor has not been cloned yet, but motilin-receptor
agonists appear to be potent prokinetic agents for the treatment of dysmoti
lity disorders. The aim of this study was to determine neural or muscular l
ocalization of motilin receptors in human upper gastrointestinal tract and
to investigate their pharmacological characteristics. The binding of I-125-
labeled motilin to tissue membranes prepared from human stomach and duoden
um was studied; rabbit tissues were used for comparison. Solutions enriched
in neural synaptosomes or in smooth muscle plasma membranes were obtained.
Various motilin analogs were used to displace the motilin radioligand from
the various tissue membranes. The highest concentration of human motilin r
eceptors was found in the antrum, predominantly in the neural preparation.
Human motilin receptors were sensitive to the NH2-terminal portion of the m
otilin molecule, but comparison with rabbit showed that both species had sp
ecific affinities for various motilin analogs [i.e., Mot-(1-9), Mot-(1-12),
Mot-(1-12) (CH2NH)(10-11), and erythromycin]. Motilin receptors obtained f
rom synaptosomes or muscular plasma membranes of human antrum expressed dif
ferent affinity for two motilin-receptor agonists, Mot-(1-12) and Mot-(1-12
) (CH2NH)(10-11), suggesting that they correspond to specific receptor subt
ypes. We conclude that human motilin receptors are located predominantly in
nerves of the antral wall, are functionally (and probably structurally) di
fferent from those found in other species such as the rabbit, and express s
pecific functional (and probably structural) characteristics dependent on t
heir localization on antral nerves or muscles, suggesting the existence of
specific receptor subtypes, potentially of significant physiological or pha
rmacological relevance.